Daan Gene Co., Ltd. (SHE:002030)
China flag China · Delayed Price · Currency is CNY
5.06
-0.01 (-0.20%)
Nov 17, 2026, 3:04 PM CST

Daan Gene Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Operating Revenue
763.32744.54843.751,17312,0407,615
Other Revenue
13.1213.129.2786.0848.84
776.43757.66853.021,18112,0467,664
Revenue Growth
1.43%-11.18%-27.77%-90.20%57.17%43.49%
Cost of Revenue
656.08668.36627.67801.123,6151,963
Gross Profit
120.3589.3225.35379.788,4315,701
Selling, General & Admin
361.69368.13333.32300.681,2461,124
Research & Development
129.78186.34225.67302.33702.4508.8
Other Operating Expenses
-16.05-22.95-18.22-8.56101.0336.34
Operating Expenses
418.24630.44936.47735.822,3471,800
Operating Income
-297.89-541.14-711.11-356.046,0843,901
Interest Expense
-4.97-4.19-9.74-10.04-13.94-9.35
Interest & Investment Income
111.897.6569.3783.1370.86266.7
Currency Exchange Gain (Loss)
-7.57-7.575.852.2825.72-1.85
Other Non Operating Income (Expenses)
-12.29-9.33-4.07-12.77-22.07-12.56
EBT Excluding Unusual Items
-210.91-464.57-649.71-293.486,4454,144
Gain (Loss) on Sale of Investments
-228.44.57-429.58409.4473.97-83.78
Gain (Loss) on Sale of Assets
2.945.489.1-3.04-1.150.11
Asset Writedown
-301.31-305.21-12.56-59.48-256.35-15
Legal Settlements
--0.071.420.46-
Other Unusual Items
2.742.7411.5258.6757.2274.44
Pretax Income
-734.94-756.99-1,071113.546,3194,120
Income Tax Expense
44.3523.53-132.0541.8891.38501.59
Earnings From Continuing Operations
-779.29-780.52-939.1171.735,4283,618
Net Income to Company
-779.29-780.52-939.1171.735,4283,618
Minority Interest in Earnings
36.3236.1413.9432.93-15.22-0.3
Net Income
-742.97-744.38-925.17104.665,4123,618
Net Income to Common
-742.97-744.38-925.17104.665,4123,618
Net Income Growth
----98.07%49.59%47.74%
Shares Outstanding (Basic)
1,3941,4041,4021,4951,4031,403
Shares Outstanding (Diluted)
1,3941,4041,4021,4951,4031,403
Shares Change
-1.54%0.19%-6.25%6.53%--
EPS (Basic)
-0.53-0.53-0.660.073.862.58
EPS (Diluted)
-0.53-0.53-0.660.073.862.58
EPS Growth
----98.19%49.59%47.74%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Free Cash Flow
240.3180.49125.92207.342,6522,646
Free Cash Flow Per Share
0.170.060.090.141.891.89
Dividend Per Share
---0.0151.7501.110
Dividend Growth
----99.14%57.66%222.86%
Gross Margin
15.50%11.79%26.42%32.16%69.99%74.39%
Operating Margin
-38.37%-71.42%-83.36%-30.15%50.51%50.90%
Profit Margin
-95.69%-98.25%-108.46%8.86%44.93%47.21%
Free Cash Flow Margin
30.95%10.62%14.76%17.56%22.02%34.52%
EBITDA
-54.25-254.47-367.05-11.826,3474,093
EBITDA Margin
-6.99%-33.59%-43.03%-1.00%52.69%53.41%
D&A For EBITDA
243.64286.68344.06344.23262.88192.02
EBIT
-297.89-541.14-711.11-356.046,0843,901
EBIT Margin
-38.37%-71.42%-83.36%-30.15%50.51%50.90%
Effective Tax Rate
---36.82%14.11%12.17%
Revenue as Reported
776.43757.66853.021,18112,0467,664